Mild Water-Filtered Near Infrared Whole-Body-Hyperthermia as an Adjunct in the Treatment of Fibromyalgia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00324441|
Recruitment Status : Completed
First Posted : May 11, 2006
Last Update Posted : May 11, 2006
|Condition or disease||Intervention/treatment||Phase|
|Fibromyalgia||Device: Iratherm® 1000||Phase 2|
Mild systemic heat agents, including infrared whole-body hyperthermia, are used as treatment options in multimodal rehabilitation programs for fibromyalgia in Germany. However, no randomized controlled clinical trial exists on their effectiveness for this condition.
This study is designed as an add-on study to evaluate the additional benefit of mild walter-filtered near infrared hyperthermia and a standard multimodal rehabilitation program compared to a standard multimodal rehabilitation program only. Standard multimodal rehabilitation is configured as usually applied in clinical trials with exercise, cognitive behavioral therapy, and health education as the main treatment components.
Mild walter-filtered near infrared hyperthermia (heating-up to 38.1 degrees C body core temperature followed by a 15-min heat retention period) is administered twice a week over 3 weeks during a rehabilitation hospital stay.
Primary outcome measures are measured at baseline, postintervention, 3 and 6 months postintervention. Analysis is done by intention to treat, for significance testing Repeated Measures ANCOVA is used.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||132 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Randomized Controlled Trial on the Effectiveness of Mild Water-Filtered Near Infrared Hyperthermia as an Adjunct to a Standard Multimodal Rehabilitation in the Treatment of Fibromyalgia|
|Study Start Date :||January 2004|
|Study Completion Date :||July 2005|
- affective pain (German version of the McGill Pain Questionnaire)
- sensory pain (German version of the McGill Pain Questionnaire)
- pain intensity (visual analogue scale)
- Fibromyalgia related quality of life(German version of the Fibromyalgia Impact Questionnaire)
- tender point assessment(mean tender point pain threshold, total tender point intensity, tender point count)
- adverse events, side effects
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00324441
|Rehabilitationsklinik Hoher Meissner|
|Bad Sooden-Allendorf, Hessen, Germany, 37242|
|Study Chair:||Thomas Brockow, MD||FBK Bad Elster|